非典型慢性淋巴细胞白血病真正意味着什么? 一个回顾性形态和免疫表型研究
Giovanni D'Arena1, Candida Vitale2, Giuseppe Pietrantuono3
1Immuno-Hematology and Transfusion Medicine Unit, "San Luca" Hospital, 84078 Vallo della Lucania, Italy.
非典型的慢性淋巴细胞白血病 (CLL) 可以通过形态学或免疫表型来确定. 形态特征更好地预测预后,而非典型的免疫类型与晚期疾病相对应.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 传统上是使用形态学标准来诊断的.
- 典型的表面免疫球蛋白配置中的偏差表明非典型的,免疫学定义的CLL.
- 形态和免疫类型的分类可能并不总是一致的.
研究的目的:
- 评估非典型的CLL的形态,免疫类型和临床生物学特征.
- 将非典型的CLL病例与典型的CLL病例进行比较.
- 评估CLL的形态和免疫类型特征的预后意义.
主要方法:
- 对大量CLL患者的回顾性评估.
- 对形态特征的评估 (FAB标准).
- 免疫类型特征分析,识别与典型的CLL特征不一致的情况.
主要成果:
- 形态上不典型的CLL表现出更高的未变异的IgVH,CD38阳性和CD20表达.
- 免疫类型非典型的CLL显示出晚期,较高的CD20,FMC7,CD79b,CD49d阳性,以及中高表面免疫球蛋白表达.
- 形态特征是时间到第一次治疗的更好的预后指标;一致的非典型病例的预后更差.
结论:
- 非典型的CLL的形态和免疫类型分类揭示了不同的特征.
- 形态学似乎是预后的更强的预测因素,而不是CLL的免疫类型.
- 形态学和免疫类型与CLL预后分子标记的临床实用性需要进一步研究.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
相关概念视频
Cell-mediated Immune Responses
Structure and Function of Leukocytes
White blood cells protect the body...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
